Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26620596 | 1.00 | CYP1A2 (0.39) | CYP1A2ALDH1A1KDM4ETDP1NPSR1 | |
| SCHEMBL27983235 | 0.88 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL28851752 | 0.87 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL27814124 | 0.80 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL28005450 | 0.78 | CYP1A2 (0.38) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL3804865 | 0.78 | CYP1A2 (0.38) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL3722471 | 0.77 | CYP1A2 (0.47) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL7964537 | 0.75 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL8966109 | 0.75 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL28462121 | 0.72 | CYP1A2 (0.34) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4442241-A2 | RETINOL REPLACEMENT IN SKIN TREATMENT | Symrise AG (DE) | 2024-10-09 | — | — | EP | claimed |
| EP-3773445-B1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2024-07-24 | — | — | EP | claimed |
| CN-107847772-B | Pharmaceutical composition containing polyalkylene glycol derivative | 西姆莱斯股份公司 | 2022-01-04 | — | — | CN | claimed |
| US-20210045983-A1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2021-02-18 | — | — | US | claimed |
| EP-3773445-A1 | RETINOL REPLACEMENT IN SKIN TREATMENT | Symrise AG (DE) | 2021-02-17 | — | — | EP | claimed |
| WO-2019185923-A1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2019-10-03 | — | — | WO | claimed |
| US-20180185301-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | SYMRISE AG (DE) | 2018-07-05 | — | — | US | claimed |
| CN-107847772-A | Pharmaceutical composition containing ployalkylene glycol derivative | 西姆莱斯股份公司 | 2018-03-27 | — | — | CN | claimed |
| WO-2016207084-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | SYMRISE AG (DE) | 2016-12-29 | — | — | WO | claimed |
| EP-3108941-A1 | COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | Symrise AG (DE) | 2016-12-28 | — | — | EP | claimed |
| EP-1959915-A1 | MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING | Symrise GmbH & Co. KG (DE) | 2008-08-27 | — | — | EP | claimed |
| CN-100387699-C | Flavoring agent component for cooling product | FIRMENICH & CIE (CH) | 2008-05-14 | — | — | CN | claimed |
| EP-1874132-A1 | HOT FLAVOUR AND SKIN SENSATION COMPOSITION | FIRMENICH SA (CH) | 2008-01-09 | — | — | EP | claimed |
| US-20080000614-A1 | HOT FLAVOR AND SKIN SENSATION COMPOSITION | FIRMENICH SA (CH) | 2008-01-03 | — | — | US | claimed |
| JP-2007516316-A | — | — | 2007-06-21 | — | — | JP | claimed |
| WO-2007062957-A1 | MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING | SYMRISE GMBH & CO. KG (DE) | 2007-06-07 | — | — | WO | claimed |
| CN-1875088-A | Flavor ingredients for cooling preparations | FIRMENICH & CIE (CH) | 2006-12-06 | — | — | CN | claimed |
| WO-2006109241-A1 | HOT FLAVOUR AND SKIN SENSATION COMPOSITION | FIRMENICH SA (CH) | 2006-10-19 | — | — | WO | claimed |
| EP-1682641-A1 | FLAVOR INGREDIENTS FOR COOLING PREPARATIONS | FIRMENICH SA (CH) | 2006-07-26 | — | — | EP | claimed |
| WO-2005042680-A1 | FLAVOR INGREDIENTS FOR COOLING PREPARATIONS | FIRMENICH SA (CH) | 2005-05-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045983-A1 | RETINOL REPLACEMENT IN SKIN TREATMENT | RBP1, RBP4, LRAT | CYP1A2 700/4885ALDH1A1 23/4885KDM4E 3115/4885 |
| US-20180185301-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | PARG, PARN, TRPV1 | CYP1A2 1066/4885ALDH1A1 3233/4885KDM4E 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.